vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Katapult Holdings, Inc. (KPLT). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $73.9M, roughly 1.6× Katapult Holdings, Inc.). Katapult Holdings, Inc. runs the higher net margin — 26.8% vs 4.2%, a 22.6% gap on every dollar of revenue. On growth, Katapult Holdings, Inc. posted the faster year-over-year revenue change (17.3% vs -1.4%). Core Laboratories Inc. produced more free cash flow last quarter ($517.0K vs $-12.0M). Over the past eight quarters, Katapult Holdings, Inc.'s revenue compounded faster (6.6% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Katapult Holdings, Inc. is a U.S.-based fintech company that provides accessible point-of-sale lease-to-purchase solutions for consumers with limited or no traditional credit history. It partners with a wide network of e-commerce platforms and brick-and-mortar retail merchants across segments including electronics, furniture and home goods to offer flexible payment plans for customers to obtain needed products.

CLB vs KPLT — Head-to-Head

Bigger by revenue
CLB
CLB
1.6× larger
CLB
$121.8M
$73.9M
KPLT
Growing faster (revenue YoY)
KPLT
KPLT
+18.8% gap
KPLT
17.3%
-1.4%
CLB
Higher net margin
KPLT
KPLT
22.6% more per $
KPLT
26.8%
4.2%
CLB
More free cash flow
CLB
CLB
$12.5M more FCF
CLB
$517.0K
$-12.0M
KPLT
Faster 2-yr revenue CAGR
KPLT
KPLT
Annualised
KPLT
6.6%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
KPLT
KPLT
Revenue
$121.8M
$73.9M
Net Profit
$5.1M
$19.8M
Gross Margin
15.6%
Operating Margin
1.5%
-1.4%
Net Margin
4.2%
26.8%
Revenue YoY
-1.4%
17.3%
Net Profit YoY
307.3%
EPS (diluted)
$0.11
$3.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
KPLT
KPLT
Q1 26
$121.8M
Q4 25
$138.3M
$73.9M
Q3 25
$134.5M
$74.0M
Q2 25
$130.2M
$71.9M
Q1 25
$123.6M
$71.9M
Q4 24
$129.2M
$63.0M
Q3 24
$134.4M
$60.3M
Q2 24
$130.6M
$58.9M
Net Profit
CLB
CLB
KPLT
KPLT
Q1 26
$5.1M
Q4 25
$4.9M
$19.8M
Q3 25
$14.2M
$-4.9M
Q2 25
$10.6M
$-7.8M
Q1 25
$-154.0K
$-5.7M
Q4 24
$7.4M
$-9.6M
Q3 24
$11.7M
$-8.9M
Q2 24
$9.0M
$-6.9M
Gross Margin
CLB
CLB
KPLT
KPLT
Q1 26
Q4 25
20.8%
15.6%
Q3 25
22.0%
19.7%
Q2 25
20.3%
15.5%
Q1 25
19.5%
19.9%
Q4 24
17.8%
11.8%
Q3 24
20.5%
19.8%
Q2 24
21.2%
16.9%
Operating Margin
CLB
CLB
KPLT
KPLT
Q1 26
1.5%
Q4 25
11.5%
-1.4%
Q3 25
15.6%
3.3%
Q2 25
11.7%
-2.0%
Q1 25
3.6%
-0.7%
Q4 24
11.0%
-7.7%
Q3 24
14.7%
-7.4%
Q2 24
12.3%
-4.5%
Net Margin
CLB
CLB
KPLT
KPLT
Q1 26
4.2%
Q4 25
3.6%
26.8%
Q3 25
10.6%
-6.7%
Q2 25
8.2%
-10.9%
Q1 25
-0.1%
-7.9%
Q4 24
5.7%
-15.2%
Q3 24
8.7%
-14.7%
Q2 24
6.9%
-11.7%
EPS (diluted)
CLB
CLB
KPLT
KPLT
Q1 26
$0.11
Q4 25
$0.11
$3.69
Q3 25
$0.30
$-0.94
Q2 25
$0.22
$-1.63
Q1 25
$0.00
$-1.23
Q4 24
$0.15
$-2.17
Q3 24
$0.25
$-2.05
Q2 24
$0.19
$-1.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
KPLT
KPLT
Cash + ST InvestmentsLiquidity on hand
$22.8M
$22.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$-38.1M
Total Assets
$587.7M
$107.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
KPLT
KPLT
Q1 26
$22.8M
Q4 25
$22.7M
$22.4M
Q3 25
$25.6M
$3.4M
Q2 25
$31.2M
$3.7M
Q1 25
$22.1M
$6.0M
Q4 24
$19.2M
$3.5M
Q3 24
$21.5M
$25.9M
Q2 24
$17.7M
$33.7M
Total Debt
CLB
CLB
KPLT
KPLT
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
KPLT
KPLT
Q1 26
$275.1M
Q4 25
$266.0M
$-38.1M
Q3 25
$271.3M
$-58.4M
Q2 25
$261.3M
$-54.1M
Q1 25
$253.4M
$-51.7M
Q4 24
$246.6M
$-46.8M
Q3 24
$250.7M
$-40.3M
Q2 24
$240.3M
$-32.9M
Total Assets
CLB
CLB
KPLT
KPLT
Q1 26
$587.7M
Q4 25
$584.0M
$107.9M
Q3 25
$591.4M
$85.9M
Q2 25
$602.1M
$90.6M
Q1 25
$591.5M
$88.5M
Q4 24
$585.1M
$93.2M
Q3 24
$600.5M
$92.0M
Q2 24
$597.8M
$106.6M
Debt / Equity
CLB
CLB
KPLT
KPLT
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
KPLT
KPLT
Operating Cash FlowLast quarter
$4.0M
$-11.9M
Free Cash FlowOCF − Capex
$517.0K
$-12.0M
FCF MarginFCF / Revenue
0.4%
-16.2%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.77×
-0.60×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
KPLT
KPLT
Q1 26
$4.0M
Q4 25
$7.9M
$-11.9M
Q3 25
$8.5M
$4.0M
Q2 25
$13.9M
$-6.6M
Q1 25
$6.7M
$3.4M
Q4 24
$20.6M
$-32.6M
Q3 24
$13.1M
$-5.4M
Q2 24
$17.1M
$-628.0K
Free Cash Flow
CLB
CLB
KPLT
KPLT
Q1 26
$517.0K
Q4 25
$5.0M
$-12.0M
Q3 25
$6.5M
$4.0M
Q2 25
$10.4M
Q1 25
$3.9M
$3.4M
Q4 24
$17.4M
$-32.6M
Q3 24
$10.4M
$-5.4M
Q2 24
$14.3M
$-653.0K
FCF Margin
CLB
CLB
KPLT
KPLT
Q1 26
0.4%
Q4 25
3.6%
-16.2%
Q3 25
4.8%
5.4%
Q2 25
8.0%
Q1 25
3.1%
4.7%
Q4 24
13.4%
-51.8%
Q3 24
7.7%
-9.0%
Q2 24
10.9%
-1.1%
Capex Intensity
CLB
CLB
KPLT
KPLT
Q1 26
Q4 25
2.1%
0.0%
Q3 25
1.5%
0.0%
Q2 25
2.7%
0.0%
Q1 25
2.3%
0.0%
Q4 24
2.5%
0.1%
Q3 24
2.0%
0.0%
Q2 24
2.2%
0.0%
Cash Conversion
CLB
CLB
KPLT
KPLT
Q1 26
0.77×
Q4 25
1.61×
-0.60×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons